Customized Treatment for PAH
In the rare lung disease pulmonary arterial hypertension (PAH), blood pressure in the pulmonary arteries increases, causing the right side of the heart to have to work much harder to pump deoxygenated blood back to the lungs. There are approximately 200,000 new cases of PAH diagnosed each year in the U.S.
In this video shared by PAH.TV in November 2015, Robert Baldrick interviews Dr. Victor Test from Duke University at CHEST 2015 in Montreal. Dr. Test talks about customized treatment for PAH patients and describes two new available medications – macitentan and riociguat.
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.